Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen | Canada Hyperbarics Skip to main content
Case Report Mycopathologia 2013

Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen

Ribeiro E, dos Santos V, Paixão G, Cruz L, Danilow M, Campos V — Mycopathologia, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the case of a 38-year-old woman with acute myeloid leukaemia and a severe fungal infection who was treated with a combination of therapies including hyperbaric oxygen.

What They Found

The patient achieved complete hematological remission from her acute myeloid leukaemia. Control CT scans showed normal results, indicating successful resolution of the invasive mucormycosis.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report, this study cannot establish that hyperbaric oxygen therapy directly caused the positive outcome, nor can its findings be generalized to a larger patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Uncategorised
Source Pubmed
PubMed ID 23443451
Year Published 2013
Journal Mycopathologia
MeSH Terms Adult; Amphotericin B; Antifungal Agents; Benzoates; Bone Marrow; Deferasirox; Drug Therapy, Combination; Female; Humans; Hyperbaric Oxygenation; Immunophenotyping; Karyotyping; Leukemia, Myeloid, Acute; Mucormycosis; Nucleophosmin; Treatment Outcome; Triazoles

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology